fatnews.com

SEARCH

Wednesday, October 17, 2018

PCSK9 INHIBITORS

5% more people given PCSK9 inhibitor evolocumab (Repatha) died from cardiovascular causes

5% more people given the PCSK9 inhibitor evolocumab (Repatha) to lower cholesterol levels died from cardiovascular causes during an average follow-up of 2.2 years than those given a placebo according to the FOURIER trial.

251 people (out of 13,784) given evolocumab died compared to 240 people (out of 13,780) given a placebo.

So they want me to take a drug that you have to inject that costs $14,000 per year that increases my chance of dying?

No, thank you.

Read the entire article | Email this article
Posted by Larry Hobbs on Wed, Oct 17, 2018 12:41 pm | [0] comments

Wednesday, November 12, 2008

PEDOMETER

People who wore pedometers increased daily steps from 6779 to 8855

Sedentary patients who were given a pedometer to wear increased the number of steps they took per day from an average of 6779 to 8855 in two months (nine weeks). Read the entire article | Email this article
Posted by Larry Hobbs on Wed, Nov 12, 2008 7:36 am | [0] comments
Follow @fatnews

QUICKLINKS AND VIEW OPITONS

  • Categories of Articles
  • Summary View
  • Headline View
  • Archive of Quotes
  • Contact Us
  • QUOTE OF THE DAY

    Books by Larry Hobbs available on Amazon

    Book cover for The Case Against Statins

    © Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.